A-shares fluctuation丨Hainan Sector surges *ST Special Treat rises to the daily limit of 20cm Hainan Expressway and Hainan Strait Shipping rise over 4%.

Gelonghui, February 7 | The Hainan Sector sharply surged, among which, *ST Puli increased by the daily limit of 20cm, Hainan Ruize New Building Material and Hainan Drinda New Energy Technology reached the daily limit, Hainan Haide Capital Management, Hainan Expressway, Hainan Strait Shipping, and Huawen Media Group rose more than 4%. Luoniushan Co., Ltd., Hainan Airport Infrastructure, and Xinlong Holding(Group)Company followed the trend. According to Statistics from Haikou Customs, during this year's Spring Festival holiday (from January 28 to February 4), Haikou Customs monitored a total of 2.094 billion yuan for duty-free shopping in the outlying islands, with 240,500 participants in duty-free shopping, an average spend of 8,706 yuan per person. In addition, the Hainan Provincial Development and Reform Commission announced that the list of major projects for Hainan Province has officially arranged 554 projects, with a total investment of 85.

Gelonghui FinanceFeb 7 10:18

Express News | *Special Treat Puli: The company's Stocks may be subject to significant illegal mandatory (Delisted).

BreakingsJan 10 21:36

A-shares move丨*Special Treat Puli hits the limit down at 20cm, reaching a new low since May 2017, with significant illegal delisting risks.

*ST Hainan Poly Pharm (300630.SZ) has hit its lower limit and is currently priced at 6.18 yuan, reaching a new low since May 2017, with a total market value dropping below 3 billion yuan. On the news front, *ST Hainan Poly Pharm received a preliminary punishment notice from the Securities Regulatory Commission for inflating revenue and profits. According to relevant regulations, the company's Stocks may be forcibly (Delisted) due to serious violations. If the company's Stocks are terminated, the Convertible Bonds will also be simultaneously delisted or canceled. It is worth mentioning that when Hainan Poly Pharm just listed on GEM, Glenn was indeed a guest of Hainan Poly Pharm, but his shareholding in Hainan Poly Pharm is not high. (Gelonghui)

Gelonghui FinanceJan 7 10:26

Hainan Poly Pharm (300630.SZ): Major violations have triggered mandatory (Delisted) status. From January 7, it will be subject to "Delisting Risk Warning."

Hainan Poly Pharm (300630.SZ) issued an announcement that the company is suspected of illegal information disclosure and has been investigated by the China Securities Regulatory Commission.

Zhitong FinanceJan 5 16:18

Express News | Hainan Poly Pharm: The company's Stocks will be subject to "Delisting Risk Warning" starting January 7, changing from "Hainan Poly Pharm" to "*ST Hainan Poly".

BreakingsJan 5 11:20

The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?

① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.

cls.cnJan 2 16:20